Wachtell Lipton was founded on a handshake in 1965 as a small group of lawyers dedicated to providing advice and expertise at the highest levels. We have achieved extraordinary results following the distinctive vision of our founders -- a cohesive team of lawyers intensely focused on solving our clients' most important problems.
Our distinctive structure defines our approach.  We maintain a ratio of associates to partners significantly below that of other firms.  We focus on matters that require the attention, extensive experience and sophistication of our partners.
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z VIEW ALL
We have experience in the fields of mergers and acquisitions, strategic investments, takeovers and takeover defense, corporate and securities law and corporate governance. We handle some of the largest, most complex and demanding transactions in the United States and around the world.
Wachtell Lipton is dedicated to providing advice and expertise at the highest levels and achieving extraordinary results for our clients. We seek individuals who are talented, motivated and committed in order to maintain our record of excellence.
Tetelbaum, Elina
Partner, Corporate
tel 212.403.1061
fax 212.403.2061

Education

  • Harvard University, A.B. 2007, magna cum laude, Phi Beta Kappa, John Harvard Scholar
  • Yale Law School, J.D. 2010, (Editor-in-Chief, Submissions Director and Articles Editor, Yale Journal on Regulation and Editor, Yale Law Journal)

Clerkships

  • Honorable Alex Kozinski, United States Court of Appeals, Ninth Circuit, 2010 - 2011

Elina Tetelbaum is a Corporate Partner at Wachtell Lipton.

Ms. Tetelbaum has advised both public and private companies in a wide range of industries in connection with mergers and acquisitions and capital markets transactions. Ms. Tetelbaum has also advised with respect to proxy contests, takeover defense strategies and other corporate governance matters. Recent transactions include:

  • Dorian LPG in its response to the $1.1 billion unsolicited proposal for all its outstanding common shares and associated proxy contest by BW LPG
  • Envision Healthcare in its $9.9 billion sale to KKR
  • Siris Capital Group in its $977 million share purchase of Intralinks
  • Perrigo Company plc in its $2.85 billion sale of its rights in the royalty stream of Tysabri® to an affiliate of Royalty Pharma
  • Valeant Pharmaceuticals International in its $1.3 billion sale of its CeraVe, Ambi and Acne Free brands and related assets to L'Oréal USA
  • Expedia in the initial public offering of its subsidiary, trivago N.V.
  • CNX Resources Corporation in its $700 million spin-off of its coal business
  • Match.Com, Inc. in its $575 million purchase of Plentyoffish Media Inc.
  • AbbVie in its $21 billion acquisition of Pharmacyclics
  • Forest Laboratories, Inc. in its $28 billion acquisition by Actavis plc.
  • Constellium N.V. in its $383 million initial public offering
  • Vulcan Materials Company in its response to the $4.7 billion unsolicited offer for all its outstanding common shares and associated proxy contest by Martin Marietta Materials, Inc.

Ms. Tetelbaum received an A.B. magna cum laude in Economics from Harvard University, as a John Harvard Scholar and was elected a member of Phi Beta Kappa. Ms. Tetelbaum completed a J.D. from Yale Law School, where she was a Paul & Daisy Soros Fellow and served as editor-in-chief of the Yale Journal on Regulation and editor of the Yale Law Journal. After law school, Ms. Tetelbaum served as a law clerk on the U.S. Court of Appeals for the Ninth Circuit.

Ms. Tetelbaum is a member of the board of directors of the Stuyvesant High School Alumni Association. Previously, she served as secretary to the Corporation Law Committee of the Association of the Bar of the City of New York.

Recent Publications